Delivery Order SPE2DX22D0049-SPE2D824FA2NG

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $57K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $166,891.44, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. Under this contract, Amerisourcebergen will provide a range of pharmaceutical products and medical...
This federal contract award, valued at $35,638.65, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $15,041.10, was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,448.54, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is a delivery order under DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $1,851.99, was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00 through December 2025. Amerisourcebergen, a major pharmaceutical distribution company, will provide a range of pharmaceutical products and medical...
This federal contract award, valued at $71,548.51, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of...
This federal contract award, valued at $38,605.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, which has a ceiling value of up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $85,574.42, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $157,900.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. Under this specific award, Amerisourcebergen will provide a variety of pharmaceutical products and medical supplies,...
This federal contract award, valued at $2,092.61, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies,...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D824FA2NG
    Delivery Order

This federal contract award, valued at $57,418.40, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of delivering logistics and acquisition services to the U.S. Armed Forces and other government agencies. This specific contract award does not have a set-aside designation, indicating it was issued on a full and open competition basis. Amerisourcebergen, through its Corporate Office division, has extensive experience in fulfilling federal pharmaceutical and medical supply contracts for government agencies.

Generated 10/7/24, 10:42 AM